StockNews.com Begins Coverage on Amarin (NASDAQ:AMRN)
StockNews.com started coverage on shares of Amarin (NASDAQ:AMRN – Free Report) in a research note published on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Amarin Stock Performance Shares of AMRN stock opened at $0.43 on Tuesday. The company has a market capitalization of $176.51 million, a price-to-earnings ratio of […]
